Skip to main content
Livermore
Livermore
ZHEN

SG Americas Securities, LLC

SEC CIK
0001313360
Latest filing
Aug 7, 2026

AMRX holding history

Amneal Pharmaceuticals, Inc. in every 13F filed by SG Americas Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMRX overviewAll 13F holders of AMRXFull Q2 2026 holdings

Shares (Q2 2026)
458,067
Value
$7.93M
% of portfolio
<0.1%
Quarters held
16
Since Q1 2021
Holdings of AMRX by SG Americas Securities, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026458,067$7.93M<0.1%−252,809−35.6%ReducedHolders
Q1 2026710,876$8.84M<0.1%−73,927−9.4%ReducedHolders
Q4 2025784,803$9.89M<0.1%+758,343+2,866.0%AddedHolders
Q3 202526,460$265.0K<0.1%−72,669−73.3%ReducedHolders
Q2 202599,129$802.0K<0.1%+3,368+3.5%AddedHolders
Q1 202595,761$802.0K<0.1%+21,243+28.5%AddedHolders
Q4 202474,518$590.0K<0.1%+10,674+16.7%AddedHolders
Q3 202463,844$531.0K<0.1%+63,844NewHolders
Q2 20240$00.0%−20,112−100.0%Sold outHolders
Q1 202420,112$122.0K<0.1%+3,177+18.8%AddedHolders
Q4 202316,935$103.0K<0.1%−35,520−67.7%ReducedHolders
Q3 202352,455$221.0K<0.1%+52,455NewHolders
Q2 20230$00.0%−43,282−100.0%Sold outHolders
Q1 202343,282$60.0K<0.1%+43,282NewHolders
Q4 20220$00.0%−62,243−100.0%Sold outHolders
Q3 202262,243$126.0K<0.1%+62,243NewHolders
Q1 20220$00.0%−15,547−100.0%Sold outHolders
Q4 202115,547$74.0K<0.1%−23,573−60.3%ReducedHolders
Q3 202139,120$209.0K<0.1%+39,120NewHolders
Q2 20210$00.0%−17,170−100.0%Sold outHolders
Q1 202117,170$116.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.